Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 2295 citing articles:

Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
Aimun Ahmed, Tom Jorna, Sunil Bhandari
˜The œNephron journals/Nephron journals (2016) Vol. 133, Iss. 3, pp. 147-158
Closed Access | Times Cited: 11640
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Joep Perk, Guy De Backer, H. Gohlke, et al.
European Heart Journal (2012) Vol. 33, Iss. 13, pp. 1635-1701
Open Access | Times Cited: 8474
Heart disease and stroke statistics-2015 update: A report from the American Heart Association
Dariush Mozaffarian, Emelia J. Benjamin, Alan S. Go, et al.
(2015) Vol. 131, Iss. 4
Open Access | Times Cited: 7076
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
François Mach, Colin Baigent, Alberico L. Catapano, et al.
European Heart Journal (2019) Vol. 41, Iss. 1, pp. 111-188
Open Access | Times Cited: 6897
Heart Disease and Stroke Statistics—2015 Update
Dariush Mozaffarian, Emelia J. Benjamin, Alan S. Go, et al.
Circulation (2014) Vol. 131, Iss. 4
Open Access | Times Cited: 5665
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Scott M. Grundy, Neil J. Stone, Alison Bailey, et al.
Circulation (2019) Vol. 139, Iss. 25
Open Access | Times Cited: 5468
Heart Disease and Stroke Statistics—2013 Update
Alan S. Go, Dariush Mozaffarian, Véronique L. Roger, et al.
Circulation (2012) Vol. 127, Iss. 1
Open Access | Times Cited: 5204
Heart Disease and Stroke Statistics—2014 Update
Alan S. Go, Dariush Mozaffarian, Véronique L. Roger, et al.
Circulation (2013) Vol. 129, Iss. 3
Open Access | Times Cited: 5172
2013 ESC guidelines on the management of stable coronary artery disease
Gilles Montalescot, Udo Sechtem, Stephan Achenbach, et al.
European Heart Journal (2013) Vol. 34, Iss. 38, pp. 2949-3003
Open Access | Times Cited: 4315
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Frank L.J. Visseren, François Mach, Yvo M. Smulders, et al.
European Heart Journal (2021) Vol. 42, Iss. 34, pp. 3227-3337
Open Access | Times Cited: 4264
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Donna K. Arnett, Roger S. Blumenthal, Michelle A. Albert, et al.
Circulation (2019) Vol. 140, Iss. 11
Open Access | Times Cited: 4174
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
François Mach, Colin Baigent, Alberico L. Catapano, et al.
Atherosclerosis (2019) Vol. 290, pp. 140-205
Open Access | Times Cited: 4171
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Francesco Cosentino, Peter J Grant, Victor Aboyans, et al.
European Heart Journal (2019) Vol. 41, Iss. 2, pp. 255-323
Open Access | Times Cited: 4110
Chronic kidney disease: global dimension and perspectives
Vivekanand Jha, Guillermo García-García, Kunitoshi Iseki, et al.
The Lancet (2013) Vol. 382, Iss. 9888, pp. 260-272
Closed Access | Times Cited: 3923
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts)
Ian D. Graham, Dan Atar, K. Borch‐Johnsen, et al.
European Heart Journal (2007) Vol. 28, Iss. 19, pp. 2375-2414
Open Access | Times Cited: 3763
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Donna K. Arnett, Roger S. Blumenthal, Michelle A. Albert, et al.
Circulation (2019) Vol. 140, Iss. 11
Open Access | Times Cited: 3506
Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
Paul E. Stevens
Annals of Internal Medicine (2013) Vol. 158, Iss. 11, pp. 825-825
Closed Access | Times Cited: 3024
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference, Henry N. Ginsberg, Ian Graham, et al.
European Heart Journal (2017) Vol. 38, Iss. 32, pp. 2459-2472
Open Access | Times Cited: 3017
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
Alberico L. Catapano, Ian Graham, Guy De Backer, et al.
European Heart Journal (2016) Vol. 37, Iss. 39, pp. 2999-3058
Open Access | Times Cited: 2849
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
Scott M. Grundy, Neil J. Stone, Alison Bailey, et al.
Journal of the American College of Cardiology (2018) Vol. 73, Iss. 24, pp. e285-e350
Open Access | Times Cited: 2101
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
Ron T. Gansevoort, Ricardo Correa‐Rotter, Brenda R. Hemmelgarn, et al.
The Lancet (2013) Vol. 382, Iss. 9889, pp. 339-352
Closed Access | Times Cited: 1945
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease
Paul E. Stevens, Sofia B. Ahmed, Juan Jesús Carrero, et al.
Kidney International (2024) Vol. 105, Iss. 4, pp. S117-S314
Open Access | Times Cited: 1904
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD
Authors Task Force Members, Lars Rydén, Peter J. Grant, et al.
European Heart Journal (2013) Vol. 34, Iss. 39, pp. 3035-3087
Open Access | Times Cited: 1863
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for the Evaluation and Management of CKD
Lesley A. Inker, Brad C. Astor, Chester H. Fox, et al.
American Journal of Kidney Diseases (2014) Vol. 63, Iss. 5, pp. 713-735
Open Access | Times Cited: 1597
Chronic kidney disease
Andrew S. Levey, Josef Coresh
The Lancet (2011) Vol. 379, Iss. 9811, pp. 165-180
Closed Access | Times Cited: 1596
Page 1 - Next Page

Scroll to top